These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 2642744)

  • 1. A ras-related gene with transformation suppressor activity.
    Kitayama H; Sugimoto Y; Matsuzaki T; Ikawa Y; Noda M
    Cell; 1989 Jan; 56(1):77-84. PubMed ID: 2642744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation suppressor genes.
    Noda M; Kitayama H; Kanazawa S; Murata S; Matsuzaki T; Ikawa Y
    Princess Takamatsu Symp; 1989; 20():233-9. PubMed ID: 2518686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations.
    Kitayama H; Matsuzaki T; Ikawa Y; Noda M
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4284-8. PubMed ID: 2112251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.
    Noda M; Kitayama H; Matsuzaki T; Sugimoto Y; Okayama H; Bassin RH; Ikawa Y
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):162-6. PubMed ID: 2463620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene.
    Burney TL; Rockove S; Eiseman JL; Jacobs SC; Kyprianou N
    Prostate; 1994 Oct; 25(4):177-88. PubMed ID: 8084835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells.
    Kondoh N; Noda M; Fisher RJ; Schweinfest CW; Papas TS; Kondoh A; Samuel KP; Oikawa T
    Biochim Biophys Acta; 1996 Aug; 1313(1):41-6. PubMed ID: 8781548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of the K-rev-1 transformation-suppressor gene.
    Kitayama H; Matsuzaki T; Sugimoto Y; Ikawa Y; Noda M
    Environ Health Perspect; 1991 Jun; 93():73-7. PubMed ID: 1773804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts.
    Ozaki T; Sakiyama S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2593-7. PubMed ID: 8385338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria.
    Kho CJ; Zarbl H
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2200-4. PubMed ID: 1549582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1.
    Rubinfeld B; Munemitsu S; Clark R; Conroy L; Watt K; Crosier WJ; McCormick F; Polakis P
    Cell; 1991 Jun; 65(6):1033-42. PubMed ID: 1904317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
    Sugimoto Y; Ikawa Y; Nakauchi H
    Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1.
    Zhang K; Noda M; Vass WC; Papageorge AG; Lowy DR
    Science; 1990 Jul; 249(4965):162-5. PubMed ID: 2115210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes that exhibit increased expression after flat reversion of NIH/3T3 cells transformed by human activated Ha-ras oncogene.
    Müllauer L; Suzuki H; Fujita H; Katabami M; Kuzumaki N
    Cancer Lett; 1991 Jul; 59(1):37-43. PubMed ID: 1878859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A domain responsible for the transformation suppressor activity in Krev-1 protein.
    Kitayama H; Matsuzaki T; Ikawa Y; Noda M
    Jpn J Cancer Res; 1990 May; 81(5):445-8. PubMed ID: 2116391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential growth factor expression in transformed mouse NIH-3T3 cells.
    Ciardiello F; Valverius EM; Colucci-D'Amato GL; Kim N; Bassin RH; Salomon DS
    J Cell Biochem; 1990 Jan; 42(1):45-57. PubMed ID: 1967612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
    Müllauer L
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.
    Krzyzosiak WJ; Shindo-Okada N; Teshima H; Nakajima K; Nishimura S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4879-83. PubMed ID: 1594588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
    Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.